 - Determine 180-day survival in patients with malignant or nonmalignant hematologic diseases treated with allogeneic umbilical cord blood transplantation. Severe aplastic anemia, Fanconi anemia, and marrow failure syndromes strata are closed to accrual; adult over 18 years of age patient stratum is closed to accrual. 